VersaBank (VBNK) Stock Chart & Stock Price History → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Free VBNK Stock Alerts $9.71 -0.14 (-1.42%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends VersaBank Stock Price Performance5 Day Performance+0.83%1 Month Performance-2.02%3 Month Performance-17.36%6 Month Performance+22.60%Year-To-Date Performance-11.32%1 Year Performance+32.47% Receive VBNK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VersaBank and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyThis military-backed stock “owns” AI marketThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. VBNK Stock Chart for Sunday, June, 2, 2024 VBNK Chart by TradingView VersaBank Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$9.85$9.71-1.42%$9.81$9.685,713 shs$252.07 million05/30/2024$9.84$9.85+0.10%$9.85$9.771,848 shs$255.71 million05/29/2024$9.63$9.84+2.18%$9.84$9.5524,124 shs$255.45 million05/28/2024$9.64$9.63-0.10%$9.80$9.639,822 shs$250.00 million05/27/2024$9.64$9.64$9.65$9.516,600 shs$250.25 million05/24/2024$9.50$9.64+1.47%$9.65$9.516,652 shs$250.25 million Get the Latest News and Ratings for VBNK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for VersaBank and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$9.63$9.50-1.35%$9.67$9.508,395 shs$246.62 million05/22/2024$9.58$9.63+0.52%$9.65$9.5030,317 shs$250.00 million05/21/2024$9.58$9.58$9.65$9.523,278 shs$248.74 million05/20/2024$9.69$9.58-1.14%$9.63$9.586,206 shs$248.70 million05/17/2024$9.63$9.60-0.31%$9.68$9.56861 shs$249.22 million05/16/2024$9.58$9.63+0.52%$9.66$9.543,918 shs$250.00 million05/15/2024$9.70$9.58-1.24%$9.74$9.583,595 shs$248.70 million05/14/2024$9.76$9.70-0.61%$9.74$9.5514,655 shs$251.81 million05/13/2024$9.68$9.76+0.83%$9.76$9.617,384 shs$253.37 million05/10/2024$9.73$9.75+0.21%$9.80$9.66643 shs$253.11 million05/09/2024$9.76$9.73-0.31%$9.77$9.684,260 shs$252.59 million05/08/2024$9.70$9.76+0.62%$9.82$9.752,110 shs$253.37 million05/07/2024$9.84$9.70-1.42%$9.82$9.636,412 shs$251.81 million05/06/2024$9.80$9.84+0.41%$9.95$9.7410,324 shs$254.45 million05/03/2024$9.91$9.80-1.11%$9.88$9.7210,070 shs$254.41 million05/02/2024$9.87$9.91+0.41%$9.92$9.881,693 shs$257.26 million05/01/2024$10.05$9.87-1.79%$10.08$9.6313,968 shs$256.23 million04/30/2024$10.04$10.05+0.10%$10.20$10.058,752 shs$260.90 million04/29/2024$9.98$10.04+0.60%$10.20$9.868,263 shs$260.64 million04/26/2024$9.91$9.88-0.30%$9.88$9.798,816 shs$256.49 million04/25/2024$9.91$9.91$9.91$9.91316 shs$257.26 million04/24/2024$9.76$9.91+1.49%$9.91$9.76912 shs$257.26 million04/23/2024$9.68$9.76+0.87%$9.86$9.6612,081 shs$253.48 million04/22/2024$9.62$9.68+0.62%$9.83$9.5810,128 shs$251.33 million04/19/2024$9.75$9.62-1.33%$9.75$9.5412,814 shs$249.74 million04/18/2024$10.01$9.75-2.60%$10.11$9.7512,308 shs$253.11 million04/17/2024$9.61$10.01+4.16%$10.01$9.712,773 shs$259.86 million04/16/2024$9.62$9.61-0.10%$9.81$9.6118,841 shs$249.48 million04/15/2024$10.03$9.62-4.09%$9.98$9.5028,961 shs$249.74 million04/12/2024$10.25$10.03-2.15%$10.22$9.9149,358 shs$260.38 million04/11/2024$10.27$10.25-0.19%$10.35$10.1663,736 shs$266.09 million04/10/2024$10.68$10.27-3.84%$10.64$10.2040,860 shs$266.61 million04/09/2024$10.73$10.68-0.47%$10.81$10.6613,558 shs$277.25 million04/08/2024$10.58$10.73+1.42%$10.90$10.6410,979 shs$278.59 millionBiotech's Best Kept Secret: Potential 46,751% Gain (Ad)The world's #1 biotech investor has been praising this stock since it was just $18.56. Even though it's rocketed 266% this year, he's now recommending a different biotech entirely!Get the name of the stock here >>>04/05/2024$10.38$10.58+1.93%$10.63$10.01213,810 shs$274.66 million04/04/2024$10.41$10.38-0.29%$10.99$10.3223,666 shs$269.51 million04/03/2024$10.37$10.41+0.39%$10.52$10.338,344 shs$270.24 million04/02/2024$10.38$10.37-0.10%$10.52$10.2714,354 shs$269.21 million04/01/2024$10.60$10.38-2.08%$10.63$10.3631,919 shs$269.47 million03/29/2024$10.60$10.60$10.74$10.569,152 shs$275.22 million03/28/2024$10.73$10.60-1.21%$10.74$10.569,144 shs$275.18 million03/27/2024$10.69$10.73+0.37%$10.79$10.528,793 shs$278.55 million03/26/2024$10.72$10.69-0.28%$10.77$10.6311,057 shs$277.51 million03/25/2024$10.79$10.72-0.64%$10.91$10.7225,569 shs$278.29 million03/22/2024$10.94$10.90-0.37%$11.00$10.792,577 shs$282.96 million03/21/2024$10.93$10.94+0.09%$11.03$10.8963,435 shs$284.00 million03/20/2024$11.06$10.93-1.18%$11.08$10.5811,343 shs$283.74 million03/19/2024$10.87$11.06+1.75%$11.15$10.9532,402 shs$287.16 million03/18/2024$10.16$10.87+6.99%$10.99$10.0031,259 shs$282.19 million03/15/2024$9.99$10.16+1.70%$10.24$9.9716,120 shs$263.75 million03/14/2024$10.13$9.99-1.38%$10.19$9.985,301 shs$259.38 million03/13/2024$10.24$10.13-1.07%$10.24$10.118,925 shs$262.98 million03/12/2024$10.08$10.24+1.59%$10.24$9.8832,583 shs$265.83 million03/11/2024$10.58$10.08-4.73%$10.44$10.0532,470 shs$261.68 million03/08/2024$10.80$10.58-2.04%$11.03$10.5372,448 shs$274.66 million03/07/2024$11.35$10.80-4.85%$11.42$10.7274,436 shs$280.37 million03/06/2024$11.90$11.35-4.62%$12.05$11.2971,792 shs$294.65 million03/05/2024$11.71$11.90+1.62%$12.03$11.68130,883 shs$308.97 million03/04/2024$11.75$11.71-0.34%$12.04$11.2557,263 shs$303.99 million03/01/2024$11.85$11.80-0.42%$12.19$11.7346,592 shs$306.33 million Related Companies: Grupo Supervielle Stock Price Chart Esquire Financial Stock Price Chart Peapack-Gladstone Financial Stock Price Chart Banco de Chile Stock Price Chart Banco Macro Stock Price Chart Bancolombia Stock Price Chart Grupo Financiero Galicia Stock Price Chart Intercorp Financial Services Stock Price Chart Summit State Bank Stock Price Chart Royal Bank of Canada Stock Price Chart Receive VBNK Stock News and Ratings via EmailSign-up to receive the latest news and ratings for VersaBank and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VBNK) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsWrite this ticker symbol down…StocksToTradeThe #1 Crypto That You Don’t Own… YetCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VersaBank Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.